latest events

QACV Consulting presented at RQA 2025 in
ICC Belfast on sustainable QA across borders

ICC Belfast, Northern Ireland | 05-07 November 2025

We are proud to announce that Erika Reategui, VP of Operations and Compliance at QACV Consulting, presented at the RQA 2025 International QA Conference in Belfast, Northern Ireland. The event gathered global quality professionals addressing the most pressing challenges in regulatory science and quality assurance.

Presentation Title: “One World, One Quality: Streamlining Sustainable QA Across Borders”

Erika’s session explored the evolving role of Quality Assurance in the face of Environmental, Social, and Governance (ESG) pressures, and the rapid globalization of clinical trials. As trial sponsors and regulators increasingly emphasize sustainability and harmonization, her talk provided practical insights on:

Minimizing travel-related emissions through hybrid and remote QA models.

Adapting quality oversight frameworks to support ESG goals.

Addressing regulatory fragmentation that slows approvals—such as varying submission formats required by the FDA (US), EMA (EU), and PMDA (Japan).

Embedding sustainability into trial design, vendor oversight, and QA governance.

Drawing from QACV Consulting’s cross-border audit expertise, Erika shared tools and strategies for harmonizing global QA processes while maintaining data integrity and compliance.

Attendees left with actionable ideas to reduce redundancy, increase operational efficiency, and align quality practices with global ESG expectations.

We appreciate all participants that attended Erika’s presentation for been part of the conversation on building a unified, future-ready QA ecosystem.

Contact us to receive a copy of her presentation.

collage of pictures from RQA 2025 in ICC Belfast
collage of pictures from RQA 2025 in ICC Belfast

05-07
NOVEMBER 2025

19-21
OCTOBER 2025

We had the incredible opportunity to attend the 22nd DIA Japan at the iconic Tokyo Big Sight in Ariake, Koto-ku.

QACV Consulting made a meaningful impact in Asia as we engaged in dynamic conversations around cross-border compliance, regulatory strategies, digital health innovation, and patient safety across the Asia-Pacific region.

As proud participants in the 22nd DIA Japan Annual Meeting, we connected with global and regional stakeholders to discuss how to deliver “Tomorrow’s Normal”—a future of healthcare that is safer, more efficient, and driven by innovation and collaboration. This year’s meeting underscored the importance of strong international partnerships—especially between Japan, the wider Asian market, and the global healthcare community—in shaping the future of medical product development and post-marketing surveillance. The introduction of an English-language track enriched the global exchange of ideas and perspectives.

It was a tremendous experience connecting with the Asian market, yielding remarkable results and forging valuable relationships. We returned inspired, informed, and more committed than ever to advancing global healthcare systems that support vibrant and healthy lives for all.

photo collage from the 22nd DIA Japan Annual Meeting
photo collage from the 22nd DIA Japan Annual Meeting

15-19
JUNE 2025

We are pleased to share that DIA 2025 in Washington, D.C. was a resounding success. Our collaboration with Ascendia Clinical was a key highlight, demonstrating the impact of strategic partnership in advancing the life sciences industry.

Together, we showecased how the integration of GxP compliance and clincial operations expertise can deliver streamlined, end-to-end solutions that meet the evolving needs of clinical research and development.

The event provided a valuable platform to engage with industry leaders, exchange insights, and explore innovative approaches that drive quality and efficiency across the drug development lifecycle.

A sincere thank you to our colleagues, partners, and all who visited our booth and attended our sessions. We look forward to building on this momentum and continuing to support meaningful progress in clinical development.

12-14
MAY 2025

QACV Consulting made its official international debut at the ISPE Europe Annual Conference, showcasing our expertise in global regulatory standards and multilingual auditing capabilities.

Our very first participation in the ISPE Europe Annual Conference was a major milestone for QACV Consulting. This event marked our official international debut, where we proudly highlighted our global reach, multilingual expertise, and deep regulatory knowledge.

It was an honor to connect with industry peers across Europe and demonstrate QACV’s growing presence on the world stage. This first international appearance marked a new chapter in our expansion—and we are just getting started.

06-11
APRIL 2025

QACV Consulting was honored to serve as a Gold Sponsor at the SQA 41st Annual Conference.

As both an exhibitor and featured presenter, QACV Consulting brought forward key discussions on global GxP auditing, regulatory harmonization, sustainability in clinical trials, and inspection readiness strategies.

Our sessions were met with strong engagement and meaningful conversations with colleagues across the industry.

It was a true pleasure to connect with so many SQA members, peers, and clients in person—strengthening partnerships and sharing our passion for quality, compliance, and continuous improvement.

We thank the SQA community for the opportunity to contribute, sponsor, and support this vital annual event. The energy, insights, and collaboration from this conference continue to inspire our global initiatives.

Thank you to everyone who visited and joined our discussions on quality, compliance, and sustainability in global clinical trials.